课题基金 / 基金详情

Florida Alzheimer's Disease Research

Florida Alzheimer's Disease Research
佛罗里达阿尔茨海默病研究
批准号:
8114260
负责人:
Huntington Potter
金额:
$87.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2012-03-31

项目摘要

项目成果

Huntington Potter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There are an estimated 430,000 Alzheimer's disease patients in Florida, with the Tampa Bay and Miami/Dade County areas having a large, ethnically diverse and growing population with this illness. Indeed, Florida is the fourth largest state in the country in terms of population, and the second largest in total number of Alzheimer's disease patients. Clearly Florida would be ideal place to site an NIA-funded Alzheimer's disease Research Center (ADRC). Yet no such Florida-based ADRC exists. Therefore, a group of researcher s and physicians from across the state have joined together to design and seek funding for the Florida ADRC (FADRC) described in this application. The general goals of the proposed FADRC are represented by the three Projects which aim: 1. To better understand the process of transition from normal to MCI to AD by determining which combinations of clinical, epidemiologic, imaging, neuropsychological, and biological markers best identify individuals who will experience a rapid rate of cognitive decline toward AD or other dementing illnesses. 2. To investigate the ability of cognitive rehabilitation to intervene in and slow disease progression in MCI and early AD patients. 3. To use mouse models of AD to determine which aspects of environmental enrichment (including cognitive rehabilitation) best slow or reverse cognitive impairment and might be similarly applied to human patients. These projects are mutually supportive and synergistic because markers found in Project 1 can be used to measure success and/or to distinguish populations in Project 2, and model results obtained in Project 3 can be used to help decide which type of intervention may be most successful in humans. The three projects are supported by 5 Cores- Clinical, Data Management, Neuropathology, Education, and Mouse Behavior and Neuropathology. The end result of the synergy inherent in the design of the FADRC may be the development a novel therapeutic intervention that can slow the clinical course of the disease. To aid in the development, administration and financial support of the planned FADRC, in 2002, the Florida Legislature established and funded the Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute on the campus of the University of South Florida. Byrd Institute funds and personnel will be used to supplement the NIA grant in a State-Federal collaboration that will help assure the success of the proposed FADRC.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1091/mbc.e09-10-0850
发表时间: 2010-02-15
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Granic A, Padmanabhan J, Norden M, Potter H]
通讯作者: Potter H
Cross-validation of the Florida Cognitive Activities Scale (FCAS) in an Alzheimer's disease research center sample.
在阿尔茨海默病研究中心样本中交叉验证佛罗里达认知活动量表 (FCAS)。
DOI: 10.1177/0891988709342724
发表时间: 2010
期刊: Journal of geriatric psychiatry and neurology
影响因子: 2.6
作者: [Schinka,JohnA, Raj,Ashok, Loewenstein,DavidA, Small,BrentJ, Duara,Ranjan, Potter,Huntington]
通讯作者: Potter,Huntington
Mild behavioral impairment as a predictor of cognitive functioning in older adults.
轻度行为障碍作为老年人认知功能的预测因子。
DOI: 10.1017/s1041610220000678
发表时间: 2021
期刊: International psychogeriatrics
影响因子: 7
作者: [Rouse,HillaryJ, Small,BrentJ, Schinka,JohnA, Loewenstein,DavidA, Duara,Ranjan, Potter,Huntington]
通讯作者: Potter,Huntington
DOI: 10.3233/jad-2010-091471
发表时间: 2010
期刊: Journal of Alzheimer's disease : JAD
影响因子: --
作者: [Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H]
通讯作者: Potter H
20
    GM-CSF/sargramostim treatment to improve cognition in Down syndrome
    • 批准号:
      10304446
    • 项目类别:
    • 资助金额:
      $34.55万
    • 财政年份:
      2021
    • 负责人:
      Huntington Potter
    • 依托单位:
    Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease
    • 批准号:
      10335221
    • 项目类别:
    • 资助金额:
      $232.62万
    • 财政年份:
      2021
    • 负责人:
      Huntington Potter
    • 依托单位:
    Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease
    • 批准号:
      10534753
    • 项目类别:
    • 资助金额:
      $259.94万
    • 财政年份:
      2021
    • 负责人:
      Huntington Potter
    • 依托单位:
    Neuronal dysfunction caused by Abeta inhibition of MT motors
    • 批准号:
      8626688
    • 项目类别:
    • 资助金额:
      $31.03万
    • 财政年份:
      2011
    • 负责人:
      Huntington Potter
    • 依托单位:
    国内基金
    海外基金
    年轻血清介导血管内皮细胞Cdk5负调控高反应性中性粒细胞浸润入脑减轻Alzheimer’s病的机制研究
    • 批准号:
      82271473
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      祁方昉
    • 依托单位:
    雌激素GPR30受体通过调节神经免疫治疗Alzheimer's病的机制研究
    基于AKT/mTOR/HIF-1a信号轴调控糖代谢重编程探讨补阳还五汤减轻炎症防治Alzheimer病的机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2021
    • 负责人:
      杨琳
    • 依托单位:
    流感疫苗联合PD-1抗体在Alzheimer’s病治疗中的作用及机制研究
    • 批准号:
      81971021
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      祁方昉
    • 依托单位: